19-41353058-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBS1BS2
The NM_000660.7(TGFB1):c.-14G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00242 in 1,512,358 control chromosomes in the GnomAD database, including 79 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.013 ( 41 hom., cov: 31)
Exomes 𝑓: 0.0013 ( 38 hom. )
Consequence
TGFB1
NM_000660.7 5_prime_UTR
NM_000660.7 5_prime_UTR
Scores
1
1
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.209
Publications
8 publications found
Genes affected
TGFB1 (HGNC:11766): (transforming growth factor beta 1) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGFB family members. This encoded protein regulates cell proliferation, differentiation and growth, and can modulate expression and activation of other growth factors including interferon gamma and tumor necrosis factor alpha. This gene is frequently upregulated in tumor cells, and mutations in this gene result in Camurati-Engelmann disease. [provided by RefSeq, Aug 2016]
TMEM91 (HGNC:32393): (transmembrane protein 91) Predicted to act upstream of or within hematopoietic progenitor cell differentiation. Predicted to be integral component of membrane. Predicted to be active in intracellular membrane-bounded organelle and membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.28).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0128 (1939/151248) while in subpopulation AFR AF = 0.0449 (1852/41262). AF 95% confidence interval is 0.0432. There are 41 homozygotes in GnomAd4. There are 906 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 41 AD,AR gene
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TGFB1 | ENST00000221930.6 | c.-14G>A | 5_prime_UTR_variant | Exon 1 of 7 | 1 | NM_000660.7 | ENSP00000221930.4 |
Frequencies
GnomAD3 genomes AF: 0.0128 AC: 1929AN: 151128Hom.: 41 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
1929
AN:
151128
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00295 AC: 337AN: 114120 AF XY: 0.00240 show subpopulations
GnomAD2 exomes
AF:
AC:
337
AN:
114120
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00126 AC: 1717AN: 1361110Hom.: 38 Cov.: 33 AF XY: 0.00109 AC XY: 731AN XY: 669642 show subpopulations
GnomAD4 exome
AF:
AC:
1717
AN:
1361110
Hom.:
Cov.:
33
AF XY:
AC XY:
731
AN XY:
669642
show subpopulations
African (AFR)
AF:
AC:
1387
AN:
30484
American (AMR)
AF:
AC:
80
AN:
33380
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
23588
East Asian (EAS)
AF:
AC:
0
AN:
34758
South Asian (SAS)
AF:
AC:
12
AN:
76222
European-Finnish (FIN)
AF:
AC:
0
AN:
33202
Middle Eastern (MID)
AF:
AC:
13
AN:
5114
European-Non Finnish (NFE)
AF:
AC:
27
AN:
1067618
Other (OTH)
AF:
AC:
198
AN:
56744
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
100
199
299
398
498
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0128 AC: 1939AN: 151248Hom.: 41 Cov.: 31 AF XY: 0.0123 AC XY: 906AN XY: 73926 show subpopulations
GnomAD4 genome
AF:
AC:
1939
AN:
151248
Hom.:
Cov.:
31
AF XY:
AC XY:
906
AN XY:
73926
show subpopulations
African (AFR)
AF:
AC:
1852
AN:
41262
American (AMR)
AF:
AC:
69
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3462
East Asian (EAS)
AF:
AC:
0
AN:
5032
South Asian (SAS)
AF:
AC:
3
AN:
4768
European-Finnish (FIN)
AF:
AC:
0
AN:
10568
Middle Eastern (MID)
AF:
AC:
0
AN:
278
European-Non Finnish (NFE)
AF:
AC:
6
AN:
67630
Other (OTH)
AF:
AC:
9
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
82
164
245
327
409
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Uncertain
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.